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Most organisms rely on innate immune receptors to recognize conserved molecular struc-
tures from invading microbes. Two essential innate immune receptors, RIG-I and MDA5,
detect viral double-stranded RNA in the cytoplasm. The inflammatory response triggered
by these RIG-I-like receptors (RLRs) is one of the first and most important lines of defense
against infection. RIG-I recognizes short RNA ligands with 5′-triphosphate caps. MDA5
recognizes long kilobase-scale genomic RNA and replication intermediates. Ligand binding
induces conformational changes and oligomerization of RLRs that activate the signaling
partner MAVS on the mitochondrial and peroxisomal membranes.This signaling process is
under tight regulation, dependent on post-translational modifications of RIG-I and MDA5,
and on regulatory proteins including unanchored ubiquitin chains and a third RLR, LGP2.
Here, we review recent advances that have shifted the paradigm of RLR signaling away
from the conventional linear signaling cascade. In the emerging RLR signaling model,
large multimeric signaling platforms generate a highly cooperative, self-propagating, and
context-dependent signal, which varies with the subcellular localization of the signaling
platform.
Keywords: pathogen-associated molecular pattern, nucleic-acid sensor, RecA-like DEAD-box (DExD/H-box)
RNA helicase, caspase recruitment domain, signal transduction, signalosome, prion-like switch, amyloid-like
aggregation
INTRODUCTION
Eukaryotic organisms rely on their innate immune system to
detect viruses and other microbes. Innate immune receptors
detect chemical patterns or structures that are broadly conserved
in microbes, including bacterial cell wall components, micro-
bial nucleic acids, and certain highly conserved proteins. These
pathogen-associated molecular patterns (PAMPs) are recognized
by pattern recognition receptors that fall into several families,
including Toll-like receptors (TLRs), NOD like receptors (NLRs),
C-type lectin receptors (CLRs), and RIG-I-like receptors (RLRs).
At the cell surface and in endocytic compartments, TLRs are
the most important family of molecular sentries for the innate
immune recognition of a wide range of microbial patterns out-
side the cytosol (1). CLRs, such as Dectin1, are localized on
the cell surface and principally recognize fungal pathogens (2).
In the cytosol, NODs and other NLRs recognize cell wall frag-
ments and other bacterial components (3). This review will
focus on the RLRs, which are found in the cytosol and recog-
nize viral double-stranded RNA (dsRNA). Innate immune recep-
tors from all families have in common that they nucleate the
assembly of large multimeric protein complexes with their sig-
naling adaptors, which include most notably MyD88, MAVS,
ASC, and RIP2 (4). These oligomeric assemblies rapidly activate
and amplify potent inflammatory antimicrobial responses, prin-
cipally through the activation of NF-κB, type I interferons, or
caspase 1.
Nucleic acids are the largest, and arguably the most important
class of ligands for innate immune receptors. To avoid signaling
in response to endogenous nucleic acids, which are ubiquitous
in the cytoplasm and nucleus, innate immune sensors must rec-
ognize specific patterns in specific subcellular locations. (1) A
subfamily of TLRs (TLRs 3, 7, 8, and 9) recognizes microbial
DNA and RNA ligands exclusively in endolysosomal compart-
ments (5–9). In the cytosol, two essential immune sensors, RIG-I
and MDA5, detect viral dsRNA (10–12). Several different sen-
sors recognize double-stranded DNA (dsDNA) in the cytoplasm,
including proteins from the AIM2 family, the DDX family, RNA
polymerase III, and cyclic GMP–AMP synthase (13, 14). Ligand
binding by each of these sensors induces a conformational change
that directs the cooperative assembly of large oligomeric signaling
platforms, leading to the recruitment and activation of signaling
adaptors (4). The rapidly ensuing inflammatory response culmi-
nates in activation of the NF-κB and type I interferon signaling
pathways (Figure 1). This response is one of the first and most
important lines of defense against infection and is responsible
for the activation of the adaptive immune system (1). Innate
immune receptors therefore play pivotal roles as master-regulators
of inflammation.
Many viruses deliver an RNA genome into the cytoplasm or
rely on a replication or transcription step that generates viral
RNA in the cytoplasm. Infection by these viruses is primarily
detected by RIG-I and MDA5, also referred to as the RLRs. RIG-
I and MDA5 sense complementary sets of viral RNA ligands
(10–12, 15). RIG-I recognizes 5′-phosphorylated blunt ends of
viral genomic dsRNA, whereas MDA5 binds internally to long
dsRNA with no end specificity (10–12). RIG-I and MDA5 both
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FIGURE 1 |The RLR signaling pathway is shown. RIG-I and MDA5
recognize a complementary set of cytosolic viral dsRNA ligands. Their
activation is tightly regulated by phosphorylation, ubiquitination, and host
proteins such as LGP2. RIG-I and MDA5 signal to MAVS, which initiates the
production of interferon signaling. Circled “P” indicates phosphorylation
and slashed circled “P” indicates dephosphorylation.
have tandem N-terminal caspase recruitment domains (CARDs)
with death domain folds, a DExD/H-box helicase (consisting of
two RecA-like helicase domains, Hel1 and Hel2, and an insert
domain, Hel2i), and a C-terminal domain (CTD) (Figure 2A). In
the absence of dsRNA, RIG-I has a closed inactive conformation
(16). RNA binding through the helicase and CTD domains (17,
18) releases the CARDs, which then recruit and activate the sig-
naling adaptor MAVS (IPS-1) (19). In contrast, MDA5 does not
sequester its CARDs (20) and cooperatively assembles into ATP-
sensitive filaments on dsRNA (20–22). Moreover, the MDA5 CTD
is required for cooperative filament assembly but not for RNA
binding (20, 23, 24). The MDA5 CARDs have been proposed to
nucleate the assembly of MAVS into its active polymeric form (20,
25) in a process that can be promoted by K63-linked polyubiq-
uitin chains (26). The self-propagating amyloid-like properties of
MAVS polymers amplify signaling (25). RLR signaling is regulated
by numerous host and viral factors through various mechanisms,
including ubiquitin-dependent proteolytic degradation and cleav-
age of MAVS by virally encoded proteases (27–29). A third RLR,
LGP2, lacks CARDs and exerts co-stimulatory and inhibitory
functions on MDA5 and RIG-I, respectively (30–33).
Recent biochemical, biophysical, and cellular studies have
greatly advanced our understanding at the molecular level of
the mechanisms of pattern recognition and signaling by RIG-I
and MDA5. Here, we review these studies and their implica-
tions on the current models of microbe-induced inflammation,
auto-inflammation, and inflammation-induced cancer.
RECOGNITION OF dsRNA IN THE CYTOSOL BY RIG-I AND
MDA5
THE MOLECULAR DETERMINANTS OF LIGAND RECOGNITION BY RLRs
RIG-I preferentially binds to short (<300 bp) dsRNAs that have
blunt ends and a 5′ triphosphate (5′-ppp) moiety, facilitating
discrimination between host and viral dsRNA (10–12). Crystal
structures of RIG-I bound to a 12-bp dsRNA ligand and of unli-
ganded RIG-I have provided detailed insights into the mechanism
of activation of this receptor. In the absence of dsRNA ligand, RIG-
I is in an auto-repressed state: the domains in the helicase domain
are in an open conformation and the tandem CARDs form con-
tacts with the Hel2i domain. This conformation sterically prevents
the CARDs from binding to polyubiquitin or to CARDs from other
binding partners, thereby preventing signaling to MAVS (16).
Upon the presentation of a viral dsRNA, RIG-I undergoes sig-
nificant conformational rearrangement. The CTD binds tightly
to the 5′-ppp and the helicase domains wrap around dsRNA,
adopting a more compact configuration (16–18) (Figure 2B).
RIG-I recognizes RNA primarily through non-specific interactions
with the phosphate sugar backbone, predominantly by the Hel2i
domain. This conformational change allows ATP to bind RIG-I, a
necessary step for the activation of RIG-I (16–18). Although the
CARDs were absent from the RNA-bound RIG-I crystal structures,
biochemical studies and small angle X-ray scattering data indicate
that the tandem CARDs are released from the Hel2i domain in the
active form of RIG-I (17, 18).
In contrast to RIG-I, MDA5 preferentially binds internally to
long dsRNA (>1,000 bp) with no end specificity (10–12) and
cooperatively assembles into a filament on the dsRNA (20, 21).
Unlike RIG-I, the CARDs of MDA5 are not sequestered in the
absence of ligand (20). The forced proximity of the CARDs upon
MDA5 filament formation induces oligomerization of MDA5
CARDs, forming a scaffold for binding and oligomerization of
MAVS CARD (see Activation of MAVS and Downstream Signal-
ing). Notably, the atomic structures of the MDA5 CARDs have not
yet been determined.
A crystal structure of the MDA5 helicase domains and CTD
bound to dsRNA revealed how MDA5, despite having a similar
domain architecture as RIG-I, recognizes dsRNA in a different
manner (Figure 2B). The helicase domains of MDA5 wrap around
dsRNA similarly to the helicase domains of RIG-I (34, 37). How-
ever, consistent with the observation that MDA5 is not prefer-
entially activated by 5′-ppp dsRNA (10–12), the MDA5 CTD is
rotated by 20°, bringing it closer to the dsRNA, as compared to the
RIG-I structure. The CTD also forms contact with Hel1 in MDA5,
such that MDA5 forms a closed ring around the dsRNA (37). This
orientation of the CTD promotes cooperative filament formation
along dsRNA, initiated from internal sites in the dsRNA rather
than from one of the ends (20, 21, 34).
The RLRs are part of the DExD/H-box helicase family based
on their domain architecture (33), but they do not appear to have
dsRNA helicase activity. Instead, ATP binding and hydrolysis have
been implicated in filament formation. ATP binding strengthens
the interaction between MDA5 and the dsRNA (34). ATP hydroly-
sis, however, causes MDA5 to dissociate from the dsRNA (20, 38).
At the ends of the MDA5-RNA filaments, ATP hydrolysis causes
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FIGURE 2 | Assembly of the RLR signalosome is shown. (A)The
domain architecture of RIG-I [colored as in Ref. (34)]. (B)Two orthogonal
views of the RIG-I (left) and MDA5 (right) helicase domains and CTD bound
to a dsRNA ligand (17). The CTD of RIG-I caps the 5′ end of the dsRNA
ligand, however, in MDA5 the CTD is rotated by 20° relative to Hel2,
allowing for MDA5 to polymerize along the dsRNA. (C)Two orthogonal
views of the RIG-I tandem CARDs, which assemble into a “lock-washer”
with three K63-di-ubiquitin molecules are shown (35). (D) RIG-I recognizes
viral dsRNA in the cytosol and undergoes a conformational change,
releasing the CARDs from an auto-repressed state. Four RIG-I molecules
come together and their CARDs assemble into an oligomer stabilized by
unanchored K63-linked polyubiquitin chains. The RIG-I CARDs serve as a
scaffold for MAVS, which forms a filament that is tethered on the
mitochondrial or peroxisomal membrane (36).
depolymerization, providing a mechanism for shutting down the
signal and for recycling of MDA5. MDA5 filament assembly and
disassembly dynamics provide the specificity for long dsRNA (20,
38). RIG-I was also shown recently to form ATP-dependent fil-
aments, although the RIG-I filaments are shorter and less stable
than MDA5 filaments (34, 39).
LGP2, the third RLR, has similar helicase and CTD domains
as RIG-I and MDA5, but it lacks the tandem CARDs (33). LGP2
recognizes the termini of dsRNA through similar types of protein-
RNA contacts as RIG-I and MDA5 (23, 33, 40, 41). ATP hydrolysis
enhances RNA recognition by LGP2 (42). Because it does not have
CARDs, LGP2 does not recruit MAVS or induce MAVS signaling.
LGP2 affects signaling in response to viral stimuli, however, by
modulating the RIG-I and MDA5 signals (see Regulation of RLR
Signaling) (30–33).
ROLE OF UNANCHORED LYSINE 63-LINKED UBIQUITIN CHAINS IN RLR
ACTIVATION
The oligomerization of the RNA sensors RIG-I and MDA5 that
activates the antiviral innate immune response depends on unan-
chored lysine 63-linked polyubiquitin chains (19, 26). In 2010,
Chen and colleagues reconstituted the RIG-I pathway in vitro and
demonstrated that unanchored K63-linked polyubiquitin chains
are required for a full signaling response as measured by IRF3
dimerization (19). Polyubiquitin chains containing as few as four
ubiquitin molecules bind non-covalently to the RIG-I CARDs and
can be covalently attached to RIG-I by the E3 ligase TRIM25 (19,
43). Furthermore, RIG-I interacted with K63-linked polyubiquitin
chains from HEK293T cells in co-immunoprecipitation experi-
ments (19). Similar studies generalized these findings to MDA5
and showed that K63-ubiquitin chains promoted oligomerization
of the MDA5 CARDs (26).
A recent crystal structure of the tandem CARDs of RIG-I bound
to K63-diubiquitin revealed the molecular basis of the CARD-
ubiquitin interaction (Figure 2C) (35). K63-ubiquitin chains
promote the assembly of RIG-I CARDs into a tetrameric “lock-
washer” structure by stabilizing intermolecular CARD–CARD
interactions. This RIG-I tetramer recruits and activates MAVS (see
next section) (35). Monoubiquitin is not sufficient to promote
RIG-I signaling because a single ubiquitin domain does not make
enough contacts to significantly stabilize RIG-I oligomerization
through CARD–CARD interactions (19, 35).
Although ubiquitin chains promote RIG-I tetramerization,
RIG-I and MDA5 can both assemble into oligomeric filaments
and induce MAVS filament formation and signaling in the absence
of polyubiquitin chains. Indeed, under certain experimental con-
ditions, namely in the absence of polyubiquitin and as a result
of ATP hydrolysis, RIG-I has been observed to form filaments
along dsRNA (34, 39, 44). Similarly, MDA5 signaling is thought to
be triggered by the formation of MDA5 filaments along dsRNA,
which is a ubiquitin-independent process (20, 21). The forced
juxtaposition of RLR CARDs upon RLR filament formation is
thought to be sufficient to activate MAVS signaling (34). Both
RIG-I CARDs and MDA5 CARDs have, however, been shown to
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bind K63 polyubiquitin chains (26). Hence the question arises of
whether K63-linked ubiquitin chains always participate in RLR
signaling, or whether they are only required under specific phys-
iological conditions that do not favor RLR filament formation.
Because RIG-I has much higher affinity for the 5′-ppp end of viral
ligands than it does for the phosphate backbone alone, it has been
proposed that RIG-I is more likely to bind to the 5′-ppp end of
the dsRNA (34). If sufficient polyubiquitin is available, RIG-I does
not form a filament and instead remains at the end of the dsRNA,
and the tetrameric CARD lock-washer scaffold is formed (34, 35).
K63-linked polyubiquitin chains stabilize the CARDs oligomer
through non-covalent interactions. Covalent linkage of the ubiq-
uitin chains to RIG-I by TRIM25 can provide further stabilization
of the RIG-I oligomer, thereby increasing interferon signaling
capacity (19, 35, 43). If the local concentration of polyubiqui-
tin is insufficient to induce RIG-I CARDs tetramer formation,
ATP hydrolysis may enable RIG-I to translocate along dsRNA
and assemble into filaments (39), bringing the CARDs together
by cooperative stacking of the helicase domains and leading to
ubiquitin-independent signal activation. Unlike RIG-I, MDA5 has
no known RNA end-preference and MDA5 has a higher propensity
to form filaments than RIG-I (26, 34). Hence, the physiological role
of unanchored polyubiquitin chains in MDA5 signaling remains
less well understood than in RIG-I.
ACTIVATION OF MAVS AND DOWNSTREAM SIGNALING
In the textbook view of RLR signaling, the signal is propagated
sequentially from the ligand-bound RLR to MAVS to the cytosolic
protein kinases IKK and TBK1, which in turn activate the tran-
scription factors NF-κB and IRF3, respectively (45). Activated NF-
κB and IRF3 are translocated into the nucleus, where they induce
expression of type I interferons and other inflammatory antimi-
crobial molecules. The discovery that ligand binding induces RIG-I
and MDA5 to assemble into large oligomeric platforms with MAVS
on the mitochondrial and peroxisomal membranes has, however,
shifted the paradigm for RLR signaling away from the model of
a linear signaling cascade. As reviewed in the previous section,
both RIG-I and MDA5 form filaments along dsRNA ligands. For
RIG-I the forced juxtaposition of its CARDs, along with binding
of K63-linked polyubiquitin chains, promotes the formation of a
tetrameric lock-washer structure (Figure 2C), which serves as a
platform to recruit MAVS (35). Structural and biochemical data
suggest that the minimal signaling unit for MDA5 is much larger
than for RIG-I and contains at least 11 MDA5 molecules (34).
These oligomeric RLR CARD assemblies have been proposed to
nucleate the formation of MAVS polymers (Figure 2D) (20, 25).
Notably, the polymeric form of MAVS, but not its monomeric
form, activates downstream RLR signaling (25). Moreover, once
MAVS polymers have been nucleated they are self-propagating,
drawing soluble-form MAVS monomers into the polymer. The
MAVS CARD, even when isolated from the C-terminal and trans-
membrane domains, recapitulates this behavior in vitro (25).
MAVS CARD polymers were recently found to consist of heli-
cal filaments (36), similar to those formed by the death domains
of MyD88 (4, 46). The switch from a soluble form to a self-
propagating helical fiber is reminiscent of amyloids and prions,
and indeed MAVS CARD functions like a bona fide prion in yeast
(47). Thus, MAVS has a prion-like mechanism of signal activation
and amplification. ASC, the adaptor of the NLRP3 inflammasome,
was recently shown to have a similar prion-like mechanism of
signal transduction (47).
A transmembrane domain tethers MAVS to the mitochondrial
or peroxisomal membrane. MAVS polymerization may therefore
cause some remodeling of the membrane in these organelles
(Figure 2D) (36). In support of this notion, MAVS facilitates cell
death by disrupting the mitochondrial membrane potential and by
activating caspases (48). Notably, the signaling output from MAVS
is different depending on whether it occurs at the peroxisomal or
mitochondrial membrane. Peroxisomal MAVS induces the rapid
interferon-independent expression of defense factors, which pre-
cedes the activation of the principal interferon-dependent pathway
by mitochondrial MAVS that amplifies and stabilizes the antivi-
ral response (49). Thus, MAVS signaling is dependent on cellular
localization, and peroxisomes are an important site of antiviral
signal transduction (49).
REGULATION OF RLR SIGNALING
The inflammatory response resulting from RLR signaling unavoid-
ably occurs at a cost to normal tissue function. Multiple regulatory
mechanisms have evolved to allow rapid activation, amplifica-
tion, and inactivation of RLR signaling, and to achieve the opti-
mal trade-off between the cost and benefit of the inflammatory
response (50). Polyubiquitination has been one of the most exten-
sively studied modifications of RIG-I and MDA5, so it is not sur-
prising that E3 ligases and deubiquitinases have been implicated
in modulating the RLR response. TRIM25, the most exhaustively
studied E3 ligase, covalently attaches K63-linked polyubiquitin to
RIG-I CARDs to initiate or promote signaling (26, 43). The E3 lig-
ase Riplet has recently been identified as a necessary component of
RIG-I signaling (51). USP21 negatively regulates RIG-I signaling
by deubiquitinating RIG-I (52).
In addition to ubiquitination, phosphorylation is slowly emerg-
ing as an important regulatory mechanism for RLR signaling.
Phosphorylation of Ser8 and Thr170 in the CARDs of RIG-I antag-
onizes RIG-I signaling (53, 54). Based on the crystal structure of
RIG-I in complex with K63-linked diubiquitin (35), we expect
phosphorylation of Ser8 but not Thr170 to interfere with ubiquitin
binding. Phosphorylation of RIG-I CARD has also been proposed
to inhibit recruitment of TRIM25 and MAVS (53, 54). The RIG-
I phosphorylation sites are not conserved in MDA5, but MDA5
does have a suppressing phosphorylation site in its first CARD,
at Ser88 (55). Conventional protein kinases Cα and β (PKCα/β)
have been identified to be responsible for RIG-I phosphorylation
(56). RIG-I and MDA5 are thought to be constitutively phospho-
rylated until presentation of viral RNA, at which time the RLRs
must be dephosphorylated by phosphoprotein phosphatase 1 α
and γ (PP1α/γ) (55).
Besides post-translational modification of the RLRs, RLR sig-
naling is also modulated by several different proteins, derived both
from the host and from pathogens. One such protein is the third
RLR, LGP2. Because it lacks CARDs, LGP2 cannot activate MAVS;
however, its ability to recognize dsRNA allows it to modulate
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the signaling capacities of RIG-I and MDA5. LGP2 downregu-
lates signaling by RIG-I (32, 33). This activity was attributed to
LGP2 competitively recognizing the same viral ligand as RIG-I.
In contrast, LGP2 enhances MDA5 signaling (30, 33, 42). The
molecular mechanism of this enhancement remains unclear, but
LGP2 appears to facilitate recognition of viral RNA by MDA5
through interactions between the LGP2 CTD and RNA (41).
Indeed, a recent study identified a specific picornaviral RNA ligand
(in the antisense L region) to which LGP2 binds tightly, thereby
stimulating MDA5 signaling (31).
The seemingly contradictory roles of LGP2 in RLR signaling
remain an open question. The experimental approaches used to
study LGP2 in relation to MDA5 and RIG-I have been different,
potentially explaining some of the differences. As evidence accu-
mulates for the opposing roles of LGP2 on RLR signaling, however,
the emerging perspective is that LGP2 can control the balance
between RIG-I and MDA5 responses during viral infection.
Pathogen evasion tactics against RLR-mediated immune
response are extensive and occur at every level of signaling
[reviewed in Ref. (57)]. A complete description of these tactics
is beyond the scope of this review, so we highlight below a few rep-
resentative examples of different modes of RLR evasion. MAVS
is the primary target of viral factors for inhibiting RLR signaling.
MAVS is cleaved by hepatitis C virus NS3/4A protease (28, 29),
enterovirus 71 protease 2Apro (58), GB virus B NS3/4A (59), and
coxsackie virus B 3C protease, which also cleaves TRIF (60). In
a distinct mechanism of RLR signal inhibition, paramyxovirus V
proteins disrupt the fold of MDA5 (61). Another major mecha-
nism for evasion of the RLR innate immune response is masking or
hiding of viral RNA ligands by viral proteins, such as VP35 from
Ebola and Marburg viruses, which coat the ends and backbone
of dsRNA to prevent RLR recognition (62–64). Similarly, nucleo-
proteins from arenaviruses bind to the ends of viral dsRNA and
digest the RNA in a 3′–5′ direction, thereby making the RNA a
weaker ligand for RLRs (65–68). Interestingly, MAVS was recently
also shown to be under cellular control. A truncated variant of
MAVS resulting from alternative translation initiation interferes
with interferon production induced by full-length MAVS (69).
CONCLUSION
RIG-I and MDA5 are the principal sensors of viral dsRNA in
the cytoplasm. The interferon-dependent inflammatory response
triggered by RLR ligand binding is one of the first and most
important lines of defense against infection. RIG-I and MDA5
recognize distinct and complementary sets of viral dsRNA lig-
ands. The molecular signaling mechanisms of RIG-I and MDA5
differ in some respects but also share certain key features. Dif-
ferences include the sequestration of CARDs by RIG-I but not
by MDA5 in the absence of ligand, the much greater propen-
sity of MDA5 to form filaments along dsRNA, and the differ-
ent contribution of K63-linked ubiquitin chains, which remains
poorly defined for MDA5. Common features in RLR signaling
include proximity-induced assembly of CARD oligomers, which
serve as platforms to nucleate MAVS CARD polymerization, and
signal amplification through the amyloid-like properties of the
MAVS CARD. Together, the recent advances reviewed here shift
the paradigm of RLR signaling away from the prototypical lin-
ear signaling cascade to a model in which signaling is activated
by the cooperative assembly of an oligomeric signaling platform.
The signal output depends on the cellular localization of MAVS
(mitochondria or perixosome), and signaling is finely regulated
by a multitude of cellular and pathogen-derived factors. Key out-
standing questions include when, where, and how ubiquitin chains
potentiate RIG-I and MDA5 signaling, exactly how RLRs inter-
act with MAVS, and how LGP2 and other factors modulate RLR
signaling.
OUTSTANDING QUESTIONS
• Do K63-linked ubiquitin chains always participate in RLR sig-
naling, or are they only required under specific physiological
conditions that do not favor RLR filament formation?
◦ Is the mechanism of action of K63-linked ubiquitin chains
the same for RIG-I and MDA5?
• What are the molecular and structural bases of MAVS activation
by RLR oligomers?
◦ How do RIG-I CARD tetramers, stabilized by K63-linked
ubiquitin, nucleate MAVS filament assembly?
◦ How do MDA5 CARDs nucleate MAVS filament assembly?
Does this process require K63-linked ubiquitin chains?
• What are the underlying molecular mechanisms for the opposite
activities of LGP2 on RIG-I and MDA5 signaling?
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